Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SURGERY PARTNERS, INC.

(SGRY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Surgery Partners, Inc. Announces Second Quarter 2021 Earnings Release Date and Conference Call Details

07/09/2021 | 10:13am EDT

BRENTWOOD, Tenn., July 09, 2021 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its second quarter 2021 results before the market opens on Wednesday, August 4, 2021, to be followed by a conference call at 8:30 a.m. (Eastern Time)

You can join the call as follows:

  • Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)
  • Replay (available 2 hours after the call and available until August 18, 2021): 1-844-512-2921 (domestic), 1-412-317-6671 (international)
  • Passcode for the live call and the replay: 13721475

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call.

To learn more about Surgery Partners, please visit the company's website at www.surgerypartners.com. Surgery Partners uses its website as a channel of distribution of material company information. Financial and other material information regarding Surgery Partners is routinely posted on the Company's website and is readily accessible. 

About Surgery Partners

Headquartered in Brentwood, Tennessee, Surgery Partners is a leading healthcare services company with a differentiated outpatient delivery model focused on providing high quality, cost effective solutions for surgical and related ancillary care in support of both patients and physicians. Founded in 2004, Surgery Partners is one of the largest and fastest growing surgical services businesses in the country, with more than 180 locations in 30 states, including ambulatory surgery centers, surgical hospitals, multi-specialty physician practices and urgent care facilities. For additional information, visit www.surgerypartners.com.

Contact:

Surgery Partners Investor Relations
(615) 234-8940
IR@surgerypartners.com


Primary Logo


© GlobeNewswire 2021
All news about SURGERY PARTNERS, INC.
09/10SURGERY PARTNERS : Cowen Starts Surgery Partners at Market Perform with $50 Pric..
MT
08/17SURGERY PARTNERS, INC. : Regulation FD Disclosure, Financial Statements and Exhi..
AQ
08/16SURGERY PARTNERS : Investor Presentation - August 2021 (PDF)
PU
08/04SURGERY PARTNERS : Management's Discussion and Analysis of Financial Condition a..
AQ
08/04Tranche Update on Surgery Partners, Inc.'s Equity Buyback Plan announced on D..
CI
08/04SURGERY PARTNERS : Posts Narrower Q2 Loss on Higher Revenue; Reiterates FY21 Gui..
MT
08/04SURGERY PARTNERS : Q2 Earnings Snapshot
AQ
08/04SURGERY PARTNERS : ANNOUNCES SECOND QUARTER 2021 RESULTS (Form 8-K)
PU
08/04SURGERY PARTNERS, INC. : Results of Operations and Financial Condition (form 8-K..
AQ
08/04SURGERY PARTNERS : Announces Second Quarter 2021 Results
AQ
More news
Analyst Recommendations on SURGERY PARTNERS, INC.
More recommendations
Financials (USD)
Sales 2021 2 217 M - -
Net income 2021 -16,4 M - -
Net Debt 2021 - - -
P/E ratio 2021 -47,3x
Yield 2021 -
Capitalization 3 791 M 3 791 M -
Capi. / Sales 2021 1,71x
Capi. / Sales 2022 1,56x
Nbr of Employees 9 950
Free-Float 38,7%
Chart SURGERY PARTNERS, INC.
Duration : Period :
Surgery Partners, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SURGERY PARTNERS, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 46,78 $
Average target price 63,57 $
Spread / Average Target 35,9%
EPS Revisions
Managers and Directors
J. Eric Evans Chief Executive Officer & Director
Thomas F. Cowhey CFO, Principal Accounting Officer & Executive VP
Wayne S. DeVeydt Executive Chairman
Varun Gadhok Chief Information Officer & Senior Vice President
Roxanne Womack Chief Compliance Officer & Senior Vice President
Sector and Competitors